Net Cash Provided by (Used in) Financing Activities of BIO-RAD LABORATORIES, INC. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIO-RAD LABORATORIES, INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $97,700,000.
  • BIO-RAD LABORATORIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $283,200,000, a 29% decline from 2024.
  • BIO-RAD LABORATORIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $218,800,000, a 49% increase from 2023.
  • BIO-RAD LABORATORIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $425,600,000, a 144% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $283,200,000 -$64,400,000 -29% 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 $218,800,000 +$206,800,000 +49% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 $425,600,000 -$1,399,200,000 -144% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 $973,600,000 +$1,029,029,000 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $55,429,000 +$467,612,000 +89% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $523,041,000 -$500,283,000 -2198% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $22,758,000 +$25,922,000 +53% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
2018 $48,680,000 -$49,021,000 -14376% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $341,000 -$8,679,000 -96% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $9,020,000 +$439,000 +5.1% 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019 2018 FY
2015 $8,581,000 -$3,108,000 -27% 01 Jan 2015 31 Dec 2015 10-K 16 Apr 2018 2017 FY
2014 $11,689,000 +$323,386,000 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $311,697,000 -$324,285,000 -2576% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $12,588,000 +$226,148,000 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $213,560,000 -$442,305,000 -193% 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2014 2013 FY
2010 $228,745,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY

BIO-RAD LABORATORIES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $97,700,000 -$97,700,000 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $0 -$4,309,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $4,309,000 -$1,185,984,000 -100% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $1,190,293,000 +$1,237,640,000 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $47,347,000 +$51,270,000 +52% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q1 2020 $98,617,000 -$100,778,000 -4663% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q1 2019 $2,161,000 -$354,000 -14% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $2,515,000 +$1,842,000 +274% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $673,000 +$415,000 +161% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $258,000 +$589,000 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $331,000 -$3,821,000 -109% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q1 2014 $3,490,000 +$10,916,000 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q1 2013 $7,426,000 -$11,145,000 -300% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $3,719,000 +$218,462,000 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $214,743,000 -$215,776,000 -20888% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q1 2010 $1,033,000 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.